Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

FOX40 interviews Frank Reynolds of InVivo Therapeutics (NVIV)

|Includes: InVivo Therapeutics Holdings Corp. (NVIV)

Sacramento’s FOX40 interviews Frank Reynolds of InVivo Therapeutics (NVIV). Mr. Reynolds discusses his own experience with paralysis and how it led to his founding of InVivo Therapeutics. He also overviews the technology that InVivo is developing and its successes to date combating spinal injury/paralysis in monkeys. Highlights of the interview include mention that the Company’s first product does not require any drugs or stem cells. It is a unique medical device that Mr. Reynolds expects to hit the market by the end of 2013. For more details on InVivo Therapeutics and the work that this innovative company is performing, download a copy of Crystal Research Associates' comprehensive Executive Informational Overview on InVivo, published in December 2011.

To view the interview on FOX40′s webpage, click here.